The Value of CD4 Point-of-Care Testing Does Point-of-Care CD4 Testing Improve Patient Retention in Care? Is Point-of-Care CD4 Testing Ready for Prime Time? References Is Point-of-Care CD4 Testing ...
Beckman Coulter Inc. is developing a test for HIV patients that it hopes will be nearly as easy to read as a pregnancy test. It will measure CD4 cells in the patient’s blood stream – a crucial factor ...
A new CD4 testing system, the BD FACSPresto Near Patient CD4 Counter system (BD Biosciences), enables patients to monitor their HIV/AIDS, potentially reducing the probability of transmitting the ...
Research in Mozambique has found that the introduction of rapid point-of-care CD4 testing* almost halved the number of patients who dropped out before starting antiretroviral therapy (ART), and nearly ...
Routine use of point-of-care CD4 testing at the time of HIV diagnosis would be cost effective in countries where health care and other resources are severely limited, experts say. A new point-of-care ...
With Gift Aid, your generous donation of £10 would be worth £12.50 at no extra cost to you. Yes, I want to Gift Aid any donations made to NAM now, in the future and in the past four years I am a UK ...
With Gift Aid, your generous donation of £10 would be worth £12.50 at no extra cost to you. Yes, I want to Gift Aid any donations made to NAM now, in the future and in the past four years I am a UK ...
SEATTLE — Patients who initiate ART without pretherapy CD4 monitoring experience a higher risk for early mortality than those who are tested, study data presented at CROI suggest. “We think that it’s ...
The Value of CD4 Point-of-Care Testing Does Point-of-Care CD4 Testing Improve Patient Retention in Care? Is Point-of-Care CD4 Testing Ready for Prime Time? References Lack of adequate laboratory ...
A new point-of-care test to measure CD4 T-cells, the prime indicator of HIV disease progression, can expedite the process leading from HIV diagnosis to antiretroviral therapy (ART) and improve ...
A new point-of-care test to measure CD4 T-cells, the prime indicator of HIV disease progression, can expedite the process leading from HIV diagnosis to antiretroviral therapy (ART) and improve ...